MedTrace Logo

Arterial Line Patency in ICU Bound COVID-19 Patients

NCT04992221 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 245

Last updated 2022-11-14

No results posted yet for this study

Summary

The health care system was completely overwhelmed by the SARS-Cov-2 virus, and ICU admissions soared as a result of the ICU doctors' increased workload. A committed crew inserts invasive line procedures to guarantee a secure and efficient performance. When COVID-19 bound patients were followed up on in the second wave, frequent requests for arterial line placement were noted. These critically ill individuals had high rates of thrombosis, which was linked to thrombotic consequences. Many factors, such as patient morbidities, insertion technique, and operational health care trained personnel's qualifications, contribute to the lowering of arterial line patency.

Our ICU management committee approved the use of systemic anticoagulation of ICU admitted patients starting on March 21, 2021 in response to an increase in the incidence of thrombosis and pulmonary embolic events in patients with COVID-19 admitted to the ICU in the second wave of the epidemic.

Conditions

  • SARS-CoV-2 ICU Bound

Interventions

PROCEDURE

arterial line

arterial line inserted for invasice mointroing and sampling

Sponsors & Collaborators

  • Hamad Medical Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-03-31
Completion
2022-04-01

Countries

  • Qatar

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04992221 on ClinicalTrials.gov